Jan. 12 at 4:38 PM
$ANTH At the end of September last year, 4,000 units managed to bring down the price of shares of Anthera Pharmaceuticals, and so far, well below 1 cent, due to this - there was no news of this decline. The company continues to participate in investment reports for the development of various drugs and financial revenues from them, and the price remains the same. It is very likely off-exchange buying at these low prices as the post below informs us, although there is not always anyone to sell if not the owners of the company and only they can create volume and volatility in the price.